Acute Cholecystitis: Indocyanine Green in Surgery

We are testing whether indocyanine green can help reduce surgery time and improve safety during gallbladder removal in patients with acute cholecystitis. This study aims to enhance surgical outcomes and patient satisfaction.

>2 years≤5 visitsMonitoring phase (IV)No PlaceboStandard MedicinesInjectionGastroenterologyOrthopedics and Traumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Indocyanine Green
Indocyanine Green is a diagnostic dye used to visualize blood flow and tissue perfusion during imaging and surgical procedures.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Germans Trias I Pujol
General and Digestive System Surgery
Badalona, Spain
Hospital Del Mar
General and Digestive System Surgery
Barcelona, Spain
Consorci Sanitari Del Maresme
General and Digestive Surgery
Mataró, Spain
Sponsor: Fundacio Parc Tauli
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.